Aniline

Aniline

SCHEMBL9867186

Nc1ccccc1.O=C1CCC(=O)O1

nearest known ligand 0.52

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 2/20 0.52
CYP1A2 P05177 3/20 0.40
CYP2C9 P11712 3/20 0.40
CYP2C19 P33261 3/20 0.40
HSD17B10 Q99714 2/20 0.40
KDM4E B2RXH2 2/20 0.40
GLA P06280 1/20 0.40
HPGD P15428 1/20 0.40
SIRT1 Q96EB6 1/20 0.40
TDP1 Q9NUW8 3/20 0.39
CYP3A4 P08684 3/20 0.39
TAAR1 Q96RJ0 1/20 0.39
CTRB1 P17538 1/20 0.37
ALOX15 P16050 1/20 0.35
MAOA P21397 4/20 0.34
MAPT P10636 3/20 0.34
ALDH1A1 P00352 2/20 0.34
L3MBTL1 Q9Y468 2/20 0.34
MAOB P27338 2/20 0.34
HTT P42858 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
3-Aminophenol SCHEMBL7993361 0.76 ALDH1A1 (0.63) TSHRCYP1A2CYP2C9CYP2C19HSD17B10
SCHEMBL29190731 0.75 TSHR (0.58) TSHRCYP1A2CYP2C9CYP2C19HSD17B10
SCHEMBL31510121 0.75 TSHR (0.58) TSHRCYP1A2CYP2C9CYP2C19HSD17B10
Phthalic Anhydride SCHEMBL8030359 0.73 TDP1 (0.70) TSHRCYP1A2CYP2C9CYP2C19HSD17B10
SCHEMBL18517570 0.72 TSHR (1.00) TSHRCYP1A2CYP2C9CYP2C19HSD17B10
Aniline SCHEMBL11803 0.72
Aniline SCHEMBL16922171 0.72
SCHEMBL22096536 0.72 TSHR (1.00) TSHRCYP1A2CYP2C9CYP2C19HSD17B10
Aniline SCHEMBL11811648 0.72 TSHR (1.00) TSHRCYP1A2CYP2C9CYP2C19HSD17B10
SCHEMBL1333224 0.72

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5019282-A Oil additives, oxidation, corrosion, wear resistance MOBIL OIL CORPORATION (US) 1991-05-28 US disclosed